Science Explorer Interactive view Map
Company · Seattle · United States

Novo Nordisk (United States)

In research, Novo Nordisk (United States) stands highest in Medicine (#4,841 of 10,443 worldwide) and Health Sciences (#6,134 of 11,982 worldwide), 2022–2025. Relative to its size it is most specialised in Endocrinology, Diabetes and Metabolism — Endocrinology, Diabetes and Metabolism is 36.5× its share of world research.

novonordisk-us.comROR OpenAlex
World rank, 2022–2025
#8,866
of 28,054 · #8,312 all time
Rank in United States
#1,182
of 4,192
Research works
630
▲ 8% vs 2013–17
Citations
22k
34.2 per fractional work
Top-10% rate
21.9%
record average 16.5%
Open access
51%
world 28%

What is Novo Nordisk (United States) known for in research?

The fields where it stands highest, 2022–2025, ranked among every institution above the floor in each field.

FieldWorld rankWhere that sitsTop-10% rateWorksAll time
MedicineField #4,841 of 10,443 20.3%101 #3714
Health SciencesDomain #6,134 of 11,982 19.7%110 #4096

Each strip is that field’s whole ranked pool, with the notch where Novo Nordisk (United States) sits in it, in the colour of the band that rank falls in. The track under the rate is the rate itself: it carries no world mark, because the world rate differs by field (from about 6% to 21% in this record).

What does Novo Nordisk (United States) specialise in?

Where its research is concentrated relative to its size: Endocrinology, Diabetes and Metabolism takes 36.5× the share of its output that it takes of world research.

  1. Endocrinology, Diabetes and MetabolismSubfield · 31.9 works37×
← less than its size predicts1×more →

Location quotient, a volume reading rather than an impact one. It surfaces small, lopsided specialities.

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Agricultural and Biological Sciences: 0.03× its world share, 0 worksAgricultural and Bio…Biochemistry, Genetics and Molecular Biology: 2.97× its world share, 26 worksBiochemistry, Geneti…Immunology and Microbiology: 1.17× its world share, 2 worksImmunology and Micro…Neuroscience: 1.21× its world share, 3 worksNeurosciencePharmacology, Toxicology and Pharmaceutics: 0.84× its world share, 0 worksPharmacology, Toxico…Chemistry: 0.45× its world share, 1 worksChemistryComputer Science: 0.28× its world share, 4 worksComputer ScienceEnergy: 0.15× its world share, 0 worksEnergyEngineering: 0.08× its world share, 2 worksEngineeringEnvironmental Science: 0.14× its world share, 1 worksEnvironmental ScienceMaterials Science: 0.18× its world share, 1 worksMaterials ScienceMathematics: 0.40× its world share, 1 worksMathematicsPhysics and Astronomy: 0.02× its world share, 0 worksPhysics and AstronomyHealth Professions: 1.99× its world share, 8 worksHealth ProfessionsMedicine: 3.25× its world share, 100 worksMedicineNursing: 0.93× its world share, 1 worksNursingArts and Humanities: 0.50× its world share, 2 worksArts and HumanitiesBusiness, Management and Accounting: 0.17× its world share, 1 worksBusiness, Management…Decision Sciences: 0.14× its world share, 0 worksDecision SciencesEconomics, Econometrics and Finance: 1.19× its world share, 4 worksEconomics, Econometr…Psychology: 0.29× its world share, 1 worksPsychologySocial Sciences: 0.06× its world share, 1 worksSocial Sciences1×world share
more than its size predictsabout as predictedless

Rings at 0.5×, 1× and 2×. Widest outward: Medicine, 3.2×. Every wedge is a field page.

Who are the top researchers at Novo Nordisk (United States)?

Ranked on the composite score, David L. Cooper, John Germak and Jonathan Bouchard lead among researchers whose main affiliation is Novo Nordisk (United States).

  1. 1 David L. Cooper United States · #426,432 worldwide 50 citations · 17 works
  2. 2 John Germak United States · #903,086 worldwide 21 citations · 20 works
  3. 3 Jonathan Bouchard United States · #1,001,186 worldwide 18 citations · 19 works
  4. 4 J Langer United States · #1,177,503 worldwide 17 citations · 22 works
All ranked researchers at Novo Nordisk (United States)

Which keywords describe research at Novo Nordisk (United States)?

By fractional works in 2022–2025, weighted toward what it does more of than the world: Glycemic Control, Insulin Therapy, Type 2 Diabetes, Obesity, Heart Failure, Cardiovascular Disease, Clinical Guidelines and Cardiovascular Outcomes.

▲ more of its work than of the world’s◆ about the world’s share▼ less than the world’s

Size is fractional works in 2022–2025 in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.

All 40 words, with their numbers
  1. Glycemic Control24▲ 99×4 topics
  2. Insulin Therapy23▲ 120×3 topics
  3. Type 2 Diabetes23▲ 64×5 topics
  4. Obesity21▲ 17×18 topics
  5. Heart Failure20▲ 29×6 topics
  6. Cardiovascular Disease20▲ 11×22 topics
  7. Clinical Guidelines17▲ 37×3 topics
  8. Cardiovascular Outcomes17▲ 195×1 topic
  9. Glucose Control17▲ 195×1 topic
  10. Diabetes15▲ 19×6 topics
  11. Metabolic Syndrome15▲ 11×15 topics
  12. Epidemiology13▲ 1.98×25 topics
  13. Inflammation12▲ 3.6×33 topics
  14. Insulin Resistance10▲ 14×6 topics
  15. Weight Loss9▲ 35×4 topics
  16. Public Health8▲ 3.5×11 topics
  17. Atherosclerosis8▲ 18×7 topics
  18. Lifestyle Intervention8▲ 59×2 topics
  19. Clinical Trials6▲ 5.6×9 topics
  20. Primary Care6▲ 9.8×8 topics
  21. Cardiovascular Risk6▲ 12×5 topics
  22. Type 1 Diabetes6▲ 43×2 topics
  23. Health Outcomes5▲ 12×4 topics
  24. Cancer Risk5▲ 14×4 topics
  25. Continuous Glucose Monitoring5▲ 69×1 topic
  26. Hypoglycemia5▲ 69×1 topic
  27. Insulin Signaling5▲ 34×2 topics
  28. Tumor Suppression5▲ 41×2 topics
  29. AMP-Activated Protein Kinase4▲ 72×1 topic
  30. Gene Therapy4▲ 15×3 topics
  31. Metformin4▲ 98×1 topic
  32. Glucose Metabolism4▲ 28×2 topics
  33. Cholesterol4▲ 19×3 topics
  34. Bariatric Surgery4▲ 78×1 topic
  35. Metabolic Surgery4▲ 78×1 topic
  36. Hepatic Steatosis4▲ 16×2 topics
  37. Global Prevalence4▲ 27×1 topic
  38. Alzheimer's Disease4▲ 8.2×4 topics
  39. Hepatocellular Carcinoma4▲ 11×2 topics
  40. NAFLD4▲ 19×1 topic

Which research topics does Novo Nordisk (United States) publish most on?

By volume in 2022–2025: Diabetes Treatment and Management, Diabetes Management and Research, Metabolism, Diabetes, and Cancer and Bariatric Surgery and Outcomes.

Diabetes Treatment and M…17Diabetes Treatment and Management: 17 fractional worksDiabetes Management and Research: 5 fractional worksMetabolism, Diabetes, and Cancer: 4 fractional worksBariatric Surgery and Outcomes: 4 fractional worksDiabetes, Cardiovascular Risks, and Lipoproteins: 4 fractional worksLiver Disease Diagnosis and Treatment: 4 fractional worksHemophilia Treatment and Research: 3 fractional worksObesity and Health Practices: 3 fractional worksPharmacology and Obesity Treatment: 3 fractional worksHealth Systems, Economic Evaluations, Quality of Life: 3 fractional works
Endocrinology, Diabetes and MetabolismMolecular BiologySurgeryEpidemiology4 others

Area is fractional works; colour is the subfield each topic belongs to.

  1. 1 Diabetes Treatment and Management Endocrinology, Diabetes and Metabolism 17 works
  2. 2 Diabetes Management and Research Endocrinology, Diabetes and Metabolism 5 works
  3. 3 Metabolism, Diabetes, and Cancer Molecular Biology 4 works
  4. 4 Bariatric Surgery and Outcomes Surgery 4 works
  5. 5 Diabetes, Cardiovascular Risks, and Lipoproteins Endocrinology, Diabetes and Metabolism 4 works
  6. 6 Liver Disease Diagnosis and Treatment Epidemiology 4 works
  7. 7 Hemophilia Treatment and Research Hematology 3 works
  8. 8 Obesity and Health Practices Pharmacy 3 works
  9. 9 Pharmacology and Obesity Treatment Pharmacology 3 works
  10. 10 Health Systems, Economic Evaluations, Quality of Life Economics and Econometrics 3 works

How open and international is its research?

Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available50.6%not open49.4%

World: 28% of research is openly available.

with international co-authors40.8%domestic only59.2%

World: 19% is written across borders.

How has Novo Nordisk (United States)'s research output changed?

Output in 2018–2022 was 8% higher than in 2013–2017.

1990200020102020
grewheldshrank

The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.

Other research institutions in Seattle

All research institutions in Seattle

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.